财中社1月9日电国药控股(01099)发布公告,董事会于2025年1月8日决议建议委任孙京林为执行董事,同时建议委任胡立刚、祖敬和邢永刚为非执行董事。这些提名是基于公司需求,并经过董事提名委员会的审议,待股东特别大会批准后生效。新任董事的任期将从股东批准之日起至本届董事会任期届满。此外,公告中提到,王刊和王鹏因工作需要于同日提出辞任非执行董事,辞任即刻生效。两位董事确认与董事会之间并无意见分歧,也...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.